Critical Congenital Heart Disease Newborn Screening Demonstration Program
Page 2

a) Enhancing and expanding the capacity of state and local public health agencies and hospitals in the process of providing screening, counseling, follow-up check-ups, performing necessary quality assurance, outcome analysis, as well as other public health surveillance functions.

b) Assisting in the process of providing health care professionals and newborn screening program personnel with ample education and knowledge on appropriate newborn screening practices, as well as on emerging technologies intended for critical congenital heart diseases.

c) Developing and administering educational programs that focus on critical congenital heart disease newborn screening, counseling, testing, follow-up, management, and treatment.

d) Establishing, sustaining, and operating a system that could coordinate and evaluate screening programs and follow-up check-ups with regards to critical congenital heart disease patients.

The Health Resources and Services Administration is willing to administer a total amount of $7,000,000 to be equally divided into seven different grant awardees.

The institutions and administrations who will be considered eligible to submit an application under this program are states or political subdivisions of a state, a consortium of two more states, a health facility, or any other entity that possess sufficient expertise in newborn screening.


Critical Congenital Heart Disease Newborn Screening Demonstration Program
  Back to Page 1

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Shared Instrumentation Grant Program
The National Institutes of Health has recently established the Shared Instrumentation Grant Program wherein they intend to solicit applications from NIH-supported research proposing to upgrade or purchase a single piece of expensive instrumentation (useful to the field of science and technology) that at a minimum costs $100,000.

---

Clinical Trials for Organ Transplantation in Children Program
The National Insitutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to establish the Clinical Trials for Organ Transplantation in Children Program wherein both agencies intend to support a group of investigators in their quest of conducting clinical trials regarding pediatric solid organ transplant recipients.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---